Background: The implementation of pharmacogenetics in clinical practice increasingly relies on multigene panels. Objectives: The objective of this study is to develop harmonized recommendations for the design and analytical implementation of multigene pharmacogenetic panels, defining clinically relevant genes and associated regions of interest (ROIs) based on evidence strength, therapeutic applicability, and compatibility with genotyping or sequencing technologies.
Picard, N., Ayme‐dietrich, E., Quaranta, S., Adam‐de‐beaumais, T., Ait tayeb, A., Alarcan, H., Amor, D., Barthelemy, D., Sassi, M., Cunat, S., Daldoul, M., Delacour, H., Etienne‐grimaldi, M.-c., Fonrose, X., Hennart, B., Lebreton, L., Malard, S., Narjoz, C., Omezzine, A., et al. (2026). French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in Pharmacogenetics. Fundamental and Clinical Pharmacology, 40(1), /. https://doi.org/10.1111/fcp.70068 (Original work published 2026)